Summary
Cardea is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors.
Deals Overview
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Senior Management
Michel Heitzen
CEO
Michael Heltzen
CEO and Co-founder
Brett Goldsmith
Chief Technology Officer
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy